Tardive Dyskinesia
Mostrando 1-12 de 39 artigos, teses e dissertações.
-
1. An examination of synaptic proteins following chronic haloperidol in a rat model of tardive dyskinesia
Tardive dyskinesia (TD) is a late-onset side effect mainly affecting the orofacial region of patients treated chronically with classic antipsychotic drugs such as haloperidol (HAL). The causes of TD remain unknown. We hypothesized that faulty synaptic re-organization might be related to TD-like syndromes and used the vacuous chewing movements (VCM) model in
Psychology & Neuroscience. Publicado em: 2010-12
-
2. EFEITOS DOS NEUROLÉPTICOS ATÍPICOS ZIPRASIDONA E AMISULPRIDA EM MODELOS ANIMAIS DE DISCINESIA TARDIA.
Tardive dyskinesia - the main side effect of long-term treatment with typical neuroleptics - has been related to nigrostriatal dopaminergic supersensitivity. Treatment with atypical neuroleptics is associated with a decreased risk for development of tardive dyskinesia. The aim of the present study was to verify the effects of several doses the atypical neuro
Publicado em: 2009
-
3. INGESTÃO DA TINTURA DE VALERIANA OFFICINALIS PROTEGE DA DISCINESIA OROFACIAL INDUZIDA POR RESERPINA EM RATOS / INTAKE OF THE VALERIANA OFFICINALIS TINCTURE PROTECTS AGAINST OROFACIAL DYSKINESIA INDUCED BY RESERPINE IN RATS
Considerando as hipóteses do papel da neurotransmissão gabaérgica e do estresse oxidativo no desenvolvimento de movimentos orais associados a neuropatologias importantes, o presente estudo investigou a possível habilidade da tintura de V. officinalis na prevenção dos movimentos de mascar no vazio (MMV) induzidos por reserpina em ratos. Os animais foram
Publicado em: 2009
-
4. INFLUÊNCIA DO ÔMEGA 3 SOBRE SINTOMAS EXTRAPIRAMIDAIS, DEFICIÊNCIA COGNITIVA E PARÂMETROS DE ESTRESSE OXIDATIVO EM ANIMAIS TRATADOS COM NEUROLÉPTICOS
Haloperidol and fluphenazine are typical neuroleptics widely used in the treatment of mental illness, whose chronic use is associated with adverse effects that affect the motor function and memory, among others. The motor disturbances can be moderate, and include parkinsonism, akathisia, dystonia, but also a more severe syndrome, known as tardive dyskinesia
Publicado em: 2009
-
5. ROLE OF DOPAMINE UPTAKE AND THEIR METABOLITES IN THE OROFACIAL DYSKINESIA INDUCED BY NEUROLEPTICS IN RATS / PAPEL DA RECAPTAÇÃO E DE METABÓLITOS DA DOPAMINA NA DISCINESIA OROFACIAL INDUZIDA POR NEUROLÉPTICOS EM RATOS
Fluphenazine-induced orofacial dyskinesia (OD) is a putative animal model of tardive dyskinesia (TD) whose pathophysiology has been related to an increase in dopamine hypersensitivity and oxidative stress. Data from literature have shown that patients with TD present a decrease in dopamine transporter (DAT) expression. In a previously study, we have demonstr
Publicado em: 2008
-
6. INFLUENCE OF PHYSICAL EXERCISE ON BEHAVIORAL PARAMETERS AND OXIDATIVE STRESS IN AN ANIMAL MODEL OF TARDIVE DYSKINESIA / IFLUÊNCIA DO EXERCÍCIO FÍSICO SOBRE PARÂMETROS DE COMPORTAMENTO E ESTRESSE OXIDATIVO EM MODELO ANIMAL DE DISCINESIA TARDIA
Regular practice of physical activity promotes beneficial effects to the body. However, excessive duration and intensity of exercise may surpass individual tolerance to exercise, generating oxidative stress (OS). Studies have shown these effects in various organs, such as the heart and muscles, but little is known about their action and mechanisms in the bra
Publicado em: 2008
-
7. EFFECT OF HIGH FAT DIET AND OF Valeriana officinalis TINCTURE ON THE CHRONIC MODEL OF OROFACIAL DYSKINESIA INDUCED BY HALOPERIDOL IN RATS / EFEITO DA DIETA HIPERLIPÍDICA E DA TINTURA DE Valeriana officinalis NO MODELO CRÔNICO DE DISCINESIA OROFACIAL INDUZIDA POR HALOPERIDOL EM RATOS
A discinesia orofacial (DO) induzida por haloperidol consiste num modelo de discinesia tardia (DT) cuja patofisiologia tem sido relacionada a um aumento na renovação de dopamina, à redução na neurotransmissão gabaérgica e ao estresse oxidativo. Existem relatos de que pacientes esquizofrênicos ingerem uma maior quantidade de gordura na dieta do que a
Publicado em: 2006
-
8. Reliability and clinical utility of a Portuguese version of the Abnormal Involuntary Movements Scale (AIMS) for tardive dyskinesia in Brazilian patients
The objective of the present study was to evaluate the reliability and clinical utility of a Portuguese version of the Abnormal Involuntary Movements Scale (AIMS). Videotaped interviews with 16 psychiatric inpatients treated with antipsychotic drugs for at least 5 years were evaluated. Reliability was assessed by the intraclass correlation coefficient (ICC)
Brazilian Journal of Medical and Biological Research. Publicado em: 2003-04
-
9. Oxiperomide in tardive dyskinesia.
Tardive dyskinesia can be suppressed by dopaminergic receptor blockers, but often at the cost of a reciprocal increase in Parkinsonism. Oxiperomide, a dopaminergic antagonist that has been shown to reduce levodopa-induced dyskinesias without producing an equal aggravation of Parkinsonism, was evaluated in a blind placebo-controlled trial in 10 patients with
-
10. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
Eleven patients with Huntington's disease and nine patients with tardive dyskinesia participated in a randomised double-blind crossover trial of sulpiride (as sole antidopaminergic therapy) versus placebo. Although functional improvement was not seen in Huntington's disease patients, sulpiride reduced movement count and total dyskinesia score in both conditi
-
11. Effect of cholinergic and anticholinergic agents on tardive dyskinesia 1
Tardive dyskinesia, like several other choreiform disorders, is felt to be primarily related to dopaminergic activity within the striatum. Physostigmine has been demonstrated to improve the abnormal movements in patients with tardive dyskinesia while scopolamine tends to aggravate abnormal movements and in some cases elicits abnormal movement not previously
-
12. State-dependent tardive dyskinesia in manic-depressive illness.
We report the occurrence of a drug-resistant tardive dyskinesia coexistent with Parkinsonism-like symptoms in a manic-depressive patient. The tardive dyskinesia completely disappeared during the manic phases and recurred after remission over the course of different mood-cycles.